Home  |  Corporate Info  |  R & D  |  Products  |  Investor Relations  |  For the Patient  |  Careers at Hemispherx  


Investor Relations
Recent News
Archived Press Releases
SEC Filings
Printed Material
Newsletter Signup



 

Information Request

Contact:

Corporate Contacts
Hemispherx Biopharma, Inc.
One Penn Center, 1617 JFK Blvd., Suite 660
Philadelphia, PA 19103
Phone: 215-988-0080
Fax: 215-988-1739
E-mail: corpcomm@hemispherx.net

Corporate Communications & Investor Relations Contacts

Dianne Will

Phone:  518-398-6222
Fax:  518-398-6369
e-mail: ir@hemispherx.net 
 

Document Request Form

Please fill out the following information; materials will be sent to you by regular mail.

Email:

First Name:

Last Name:

Address:

City:

State:

Zip:

Phone:

 

 Add my e-mail address to the broadcast list

Thank you for requesting these documents.

Press Release Alert - receive information by email every time a press release is issued
 

 

Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgement as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements.